Adoptive transfer of helminth antigen-pulsed dendritic cells protects against the development of experimental colitis in mice. (Q41019894)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Adoptive transfer of helminth antigen-pulsed dendritic cells protects against the development of experimental colitis in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Gabriella Leung

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

José L Reyes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Chelsea E Matisz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Arthur Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Derek M McKay

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

25 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

3126-3139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26332354%20AND%20SRC:MED&resulttype=core&format=json

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Diversity and dialogue in immunity to helminths.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Helminth parasites--masters of regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Helminth infections decrease host susceptibility to immune-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Helminth antigens enable CpG-activated dendritic cells to inhibit the symptoms of collagen-induced arthritis through Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

The hygiene theory harnessing helminths and their ova to treat autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Trichuris suis therapy in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Parasitic helminths: a pharmacopeia of anti-inflammatory molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Unconventional maturation of dendritic cells induced by particles from the laminated layer of larval Echinococcus granulosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Modulation of specific and allergy-related immune responses by helminths

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Dendritic cell based vaccines for HIV infection: the way ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

A key role of dendritic cells in probiotic functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Adoptive transfer of dendritic cells isolated from helminth-infected mice enhanced T regulatory cell responses in airway allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Application of dendritic cells stimulated with Trichinella spiralis excretory-secretory antigens alleviates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

IL-10 gene therapy prevents TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Recombinant human interleukin 10 for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

IL-10 therapy in Crohn's disease: at the crossroads. Treatment of Crohn's disease with the anti-inflammatory cytokine interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

A novel regulatory macrophage induced by a helminth molecule instructs IL-10 in CD4+ T cells and protects against mucosal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Intestinal nematode infection ameliorates experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

Excretory-secretory products (ESP) from Fasciola hepatica induce tolerogenic properties in myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

7 January 2021

Induction of interferon-gamma by Taenia crassiceps glycans and Lewis sugars in naive BALB/c spleen and peritoneal exudate cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

7 January 2021

Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

7 January 2021

Induction of enhanced immunity to intestinal nematodes using IL-9-producing dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

7 January 2021

Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545579

7 January 2021